TCL Archive In Brief: ACOS Moves Up Schedule for TNM Staging System From 1986 To “As Expeditiously As Possible” January 13, 1984
TCL Archive In Brief: visco Named to Cancer Policy Board; Foundation Pledges $6.5 Million to Karmanos May 9, 1997
TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
